释义 |
dexamethasoneenUK
dex·a·meth·a·sone D0186400 (dĕk′sə-mĕth′ə-sōn′, -zōn′)n. A synthetic glucocorticoid, C22H29FO5, used in the treatment of insufficient adrenocortical function, a variety of inflammatory disorders such as arthritis and ulcerative colitis, and certain types of cancer. [dexa- (blend of deca- hexa-) + meth(yl) + alteration of (predn)is(ol)one.]dexamethasone (ˌdɛksəˈmɛθəˌsəʊn) na type of powerful steroid, used as an anti-inflammatory and immunosuppressantThesaurusNoun | 1. | dexamethasone - a corticosteroid drug (trade names Decadron or Dexamethasone Intensol or Dexone or Hexadrol or Oradexon) used to treat allergies or inflammationDecadron, Dexamethasone Intensol, Dexone, Hexadrol, Oradexonanti-inflammatory, anti-inflammatory drug - a medicine intended to reduce inflammationadrenal cortical steroid, corticoid, corticosteroid - a steroid hormone produced by the adrenal cortex or synthesized; administered as drugs they reduce swelling and decrease the body's immune response; "adrenal cortical steroids are used to treat many different conditions" | TranslationsEncyclopediaSeeGlucocorticoidsdexamethasoneenUK
dexamethasone [dek″sah-meth´ah-sōn] a synthetic steroid antiinflammatory agent used for various conditions, including collagen diseases and allergic states; it is also used for replacement therapy in adrenal insufficiency and in a screening test for the diagnosis of cushing's syndrome.dexamethasone Apo-Dexamethasone (CA), Dexasone, Ozurdex dexamethasone sodium phosphatePharmacologic class: Glucocorticoid Therapeutic class: Anti-inflammatory Pregnancy risk category C Action Unclear. Reduces inflammation by suppressing polymorphonuclear leukocyte migration, reversing increased capillary permeability, and stabilizing leukocyte lysosomal membranes. Also suppresses immune response (by reducing lymphatic activity), stimulates bone marrow, and promotes protein, fat, and carbohydrate metabolism. Availability Elixir: 0.5 mg/5 ml Intravitreal implant: 0.7 mg Oral solution: 0.5 mg/5 ml, 1 mg/ml Solution for injection (sodium phosphate): 4 mg/ml, 10 mg/ml, 20 mg/ml, 24 mg/ml Tablets: 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, 1.5 mg, 2 mg, 4 mg, 6 mg Indications and dosages ➣ Macular edema following branch retinal vein occlusion or central retinal vein occlusion; noninfectious uveitis affecting posterior segment of eye Adults: 0.7 mg by intravitreal implant ➣ Allergic and inflammatory conditions Adults: 0.75 to 9 mg/day (dexamethasone) P.O. as a single dose or in divided doses; in severe cases, much higher dosages may be needed. Dosage requirements vary and must be individualized based on disease and patient response. ➣ Cerebral edema Adults: Initially, 10 mg (sodium phosphate) I.V., followed by 4 mg I.M. q 6 hours. Then reduce dosage gradually over 5 to 7 days. ➣ Suppression test for Cushing's syndrome Adults: 1 mg P.O. at 11 P.M. or 0.5 mg P.O. q 6 hours for 48 hours (with urine collection testing, as ordered) Off-label uses • Acute altitude sickness • Bacterial meningitis • Bronchopulmonary dysplasia in preterm infants • Hirsutism • Suppression test for detection, diagnosis, or management of depression Contraindications • Hypersensitivity to drug, benzyl alcohol, bisulfites, EDTA, creatinine, polysorbate 80, or methylparaben • Systemic fungal infections • Active or suspected ocular or periocular infections, advanced glaucoma (intravitreal implant) Precautions Use cautiously in: • renal insufficiency, cirrhosis, diabetes mellitus, diverticulitis, GI disease, cardiovascular disease, hypoprothrombinemia, hypothyroidism, myasthenia gravis, glaucoma, osteoporosis, infections, underlying immunosuppression, psychotic tendencies • pregnant or breastfeeding patients • children. Administration • Give P.O. dose with food or milk. • When giving I.M., inject deep into gluteal muscle; rotate sites as needed. • For I.V. use, drug may be given undiluted as a single dose over 1 minute or added to dextrose or I.V. saline solutions and given as an intermittent infusion at prescribed rate. Adverse reactions CNS: headache, malaise, vertigo, psychiatric disturbances, increased intracranial pressure, seizures CV: hypotension, thrombophlebitis, myocardial rupture after recent myocardial infarction, thromboembolism EENT: cataracts; elevated intraocular pressure (IOP), conjunctival hemorrhage (with intravitreal implant) GI: nausea, vomiting, abdominal distention, dry mouth, anorexia, peptic ulcer, bowel perforation, pancreatitis, ulcerative esophagitis Metabolic: decreased carbohydrate tolerance, hyperglycemia, cushingoid appearance (moon face, buffalo hump), decreased growth (in children), latent diabetes mellitus, sodium and fluid retention, negative nitrogen balance, adrenal suppression, hypokalemic alkalosis Musculoskeletal: muscle wasting, muscle pain, osteoporosis, aseptic joint necrosis, tendon rupture, long bone fractures Skin: diaphoresis, angioedema, erythema, rash, pruritus, urticaria, contact dermatitis, acne, decreased wound healing, bruising, skin fragility, petechiae Other: facial edema, weight gain or loss, increased susceptibility to infection, hypersensitivity reactions Interactions Drug-drug. Barbiturates, phenytoin, rifampin: decreased dexamethasone effects Digoxin: increased risk of digoxin toxicity Ephedrine: increased dexamethasone clearance Estrogen, hormonal contraceptives: blocking of dexamethasone metabolism Fluoroquinolones: increased risk of tendon rupture Itraconazole, ketoconazole: increased dexamethasone blood level and effects Live-virus vaccines: decreased antibody response to vaccine, increased risk of adverse reactions Loop and thiazide diuretics: additive hypokalemia Nonsteroidal anti-inflammatory drugs: increased risk of GI adverse effects Somatrem, somatropin: decreased response to these drugs Drug-diagnostic tests. Calcium, potassium: decreased levels Cholesterol, glucose: increased levels Nitroblue tetrazolium test: false-negative result Drug-herbs. Echinacea: increased immune-stimulating effect Ginseng: potentiation of immunemodulating response Drug-behaviors. Alcohol use: increased risk of gastric irritation and GI ulcers Patient monitoring • Monitor blood glucose level closely in diabetic patients receiving drug orally. • Monitor hemoglobin and potassium levels. • Assess for occult blood loss. See In long-term therapy, never discontinue drug abruptly. Dosage must be tapered gradually. • Monitor patient for increased IOP after intravitreal injection. Patient teaching See Instruct patient to immediately report sudden weight gain, swelling of face or limbs, excessive nervousness or sleep disturbances, excessive body hair growth, vision changes, difficulty breathing, muscle weakness, persistent abdominal pain, or change in stool color. • Tell patient to take oral drug with or after meals. • Advise patient to report vision changes and if eye becomes red, sensitive to light, or painful after intravitreal implant, to promptly report this to ophthalmologist. • Inform patient that drug makes him more susceptible to infection. Advise him to avoid crowds and exposure to illness. See Caution patient not to stop taking drug abruptly. • As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs, tests, herbs, and behaviors mentioned above. dex·a·meth·a·sone (dek'să-meth'ă-sōn), A potent synthetic analogue of cortisol, with similar biologic action; used as an antiinflammatory agent and as a test material for adrenal cortical function.dexamethasone (dĕk′sə-mĕth′ə-sōn′, -zōn′)n. A synthetic glucocorticoid used to treat inflammatory disorders.dex·a·meth·a·sone (DM) (dek'să-meth'ă-sōn) A potent synthetic analogue of cortisol, with similar biologic action; used as an antiinflammatory agent and as a test material for adrenal cortical function. dexamethasone A synthetic CORTICOSTEROID drug used for its anti-inflammatory action and for its value in reducing OEDEMA of the brain. It is also used to treat severe inflammatory and allergic disorders, shock, congenital adrenal hyperplasia, vomiting caused by chemotherapy, and for the diagnosis of Cushing's disease. The drug is on the WHO official list. Brand names are Decadron and Dexsol. The drug is also used in various combinations.antiinflammatory drug A drug which inhibits or suppresses most inflammatory responses of an allergic, bacterial, traumatic or anaphylactic origin, as well as being immunosuppressant. They include the corticosteroids (e.g. betamethasone, dexamethasone, fluorometholone, hydrocortisone acetate, loteprednol etabonate, prednisolone, rimexolone, triamcinolone). They are sometimes combined with an antibiotic drug (e.g. betamethasone combined with neomycin or sulfacetamide, dexamethasone combined with neomycin or polymyxin B). Corticosteroids have side effects, such as enhancing the activity of herpes simplex virus, fungal overgrowth, raising intraocular pressure or cataract formation.There are other antiinflammatory drugs that are non-steroidal (NSAID) and have little toxicity. They act mainly by blocking prostaglandin synthesis. These include diclofenac sodium, flurbiprofen sodium, indomethacin, ketorolac, nepafenac and oxyphenbutazone. See immunosuppressants; steroid.dex·a·meth·a·sone (dek'să-meth'ă-sōn) Potent synthetic analogue of cortisol, with similar action; used as an antiinflammatory and to test for adrenal cortical function. dexamethasoneenUK Related to dexamethasone: Dexamethasone suppression testSynonyms for dexamethasonenoun a corticosteroid drug (trade names Decadron or Dexamethasone Intensol or Dexone or Hexadrol or Oradexon) used to treat allergies or inflammationSynonyms- Decadron
- Dexamethasone Intensol
- Dexone
- Hexadrol
- Oradexon
Related Words- anti-inflammatory
- anti-inflammatory drug
- adrenal cortical steroid
- corticoid
- corticosteroid
|